Summary
Personalised Medicine (PerMed) approaches bring along immense potentials to improve diagnosis and treatment of diseases and prevention strategies by taking into account individuals' geno- and phenotypes, biomedical, life style or environmental data. The International Consortium for Personalised Medicine (ICPerMed) is a member state driven initiative of over 40 international ministries and funding agencies. The European Commission (EC) is an active observer and supports by funding several related projects. ICPerMed aims at aligning efforts in all areas of PerMed by fostering international coordination of research and innovation funding.
To support these efforts “Widening Sino‐EU policy and research cooperation in Personalised Medicine” (Sino-EU-PerMed) aims at connecting ICPerMed strategies and activities with relevant Chinese stakeholders. To achieve this goal the Sino-EU-PerMed will disseminate and coordinate the following activities. Inventory and analysis of the PerMed landscape in China via a mapping. In addition the Sino-EU-PerMed consortium will exchange expertise and experts by workshops and via delegation trips in China and Europe. Thereby we will gain a better mutual understanding of PerMed activities and related cultural aspects and health economy issues. By establishing technical taskforces and running a series of targeted workshops Sino-EU-PerMed will promote international standards and pave the way for future communication, collaboration and undertakings. Therefore the implementation of a dissemination plan is part of the project.
Our consortium and activities aim at maximising the unique and long-term impact PerMed approaches in cooperation and in alignment with ICPerMed. The cooperation with China set up and planned in Sino-EU-PerMed will allow ICPerMed to further strengthen Europe's leading role in this area and contribute to a successful implementation of PerMed in the global context and foster joint PerMed projects between Europe and China.
To support these efforts “Widening Sino‐EU policy and research cooperation in Personalised Medicine” (Sino-EU-PerMed) aims at connecting ICPerMed strategies and activities with relevant Chinese stakeholders. To achieve this goal the Sino-EU-PerMed will disseminate and coordinate the following activities. Inventory and analysis of the PerMed landscape in China via a mapping. In addition the Sino-EU-PerMed consortium will exchange expertise and experts by workshops and via delegation trips in China and Europe. Thereby we will gain a better mutual understanding of PerMed activities and related cultural aspects and health economy issues. By establishing technical taskforces and running a series of targeted workshops Sino-EU-PerMed will promote international standards and pave the way for future communication, collaboration and undertakings. Therefore the implementation of a dissemination plan is part of the project.
Our consortium and activities aim at maximising the unique and long-term impact PerMed approaches in cooperation and in alignment with ICPerMed. The cooperation with China set up and planned in Sino-EU-PerMed will allow ICPerMed to further strengthen Europe's leading role in this area and contribute to a successful implementation of PerMed in the global context and foster joint PerMed projects between Europe and China.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/874556 |
| Start date: | 01-01-2020 |
| End date: | 30-06-2024 |
| Total budget - Public funding: | 2 338 650,00 Euro - 1 999 250,00 Euro |
Cordis data
Original description
Personalised Medicine (PerMed) approaches bring along immense potentials to improve diagnosis and treatment of diseases and prevention strategies by taking into account individuals' geno- and phenotypes, biomedical, life style or environmental data. The International Consortium for Personalised Medicine (ICPerMed) is a member state driven initiative of over 40 international ministries and funding agencies. The European Commission (EC) is an active observer and supports by funding several related projects. ICPerMed aims at aligning efforts in all areas of PerMed by fostering international coordination of research and innovation funding.To support these efforts “Widening Sino‐EU policy and research cooperation in Personalised Medicine” (Sino-EU-PerMed) aims at connecting ICPerMed strategies and activities with relevant Chinese stakeholders. To achieve this goal the Sino-EU-PerMed will disseminate and coordinate the following activities. Inventory and analysis of the PerMed landscape in China via a mapping. In addition the Sino-EU-PerMed consortium will exchange expertise and experts by workshops and via delegation trips in China and Europe. Thereby we will gain a better mutual understanding of PerMed activities and related cultural aspects and health economy issues. By establishing technical taskforces and running a series of targeted workshops Sino-EU-PerMed will promote international standards and pave the way for future communication, collaboration and undertakings. Therefore the implementation of a dissemination plan is part of the project.
Our consortium and activities aim at maximising the unique and long-term impact PerMed approaches in cooperation and in alignment with ICPerMed. The cooperation with China set up and planned in Sino-EU-PerMed will allow ICPerMed to further strengthen Europe's leading role in this area and contribute to a successful implementation of PerMed in the global context and foster joint PerMed projects between Europe and China.
Status
SIGNEDCall topic
SC1-HCO-01-2018-2019-2020Update Date
26-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Search
Organisations
